Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Not quite break even but close
View:
Post by LithLover on Nov 14, 2022 11:33pm

Not quite break even but close

$42,626 cash used in the last 3 months with short term loan proceeds of $181,346.
Comment by Pacman28 on Nov 15, 2022 8:12am
lol. looks like they'll do 4 million this yr. same as Care Oncology did on their own. Makes sense??
Comment by TrippinAgain01 on Nov 15, 2022 8:22am
At this rate, SZLS may gain traction in the market by 2058 lol, talk about moving at a snails pace. If SZ had any common sense they would get a large company on board to legitimize Aristotle, but we all know this product is more than likely to be fake. If it really is what they claim it is, why after 20 months does not a single company want to join with them? Notice how the Aristotle sales numbers ...more  
StageZero Life Sciences Ltd